A detailed history of Janney Montgomery Scott LLC transactions in Dbv Technologies S.A. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 23,546 shares of DBVT stock, worth $19,778. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,546
Previous 23,546 -0.0%
Holding current value
$19,778
Previous $22,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

SELL
$1.28 - $1.73 $2,757 - $3,726
-2,154 Reduced 8.38%
23,546 $40,000
Q3 2022

Oct 25, 2022

SELL
$1.77 - $2.76 $7,080 - $11,040
-4,000 Reduced 13.47%
25,700 $45,000
Q3 2021

Oct 29, 2021

SELL
$4.71 - $5.92 $9,420 - $11,840
-2,000 Reduced 6.31%
29,700 $146,000
Q1 2021

Apr 27, 2021

BUY
$2.75 - $6.57 $6,875 - $16,425
2,500 Added 8.56%
31,700 $169,000
Q4 2020

Jan 25, 2021

BUY
$1.38 - $3.01 $40,296 - $87,892
29,200 New
29,200 $77,000

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $158M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.